GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk

Documenti analoghi

• Components of Adolescent Behavioural Interventions With Eating Disorder Outcomes: Systematic Review With Intervention Mapping
  di: Natalie B. Lister, et al.
  Pubblicazione: (2025)
• Facets of Dietary Restraint Associated With Disordered Eating Behaviors Among Children and Adolescents With Higher Weight
  di: Laura D'Adamo, et al.
  Pubblicazione: (2025)
• GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
  di: Hao Dai, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
  di: Binayak Sinha, et al.
  Pubblicazione: (2025)
• Correction to ‘Changes in Eating Behaviour During Treatment With Obesity Medications’
  Pubblicazione: (2026)